Studies have demonstrated that PFKFB4 is highly expressed in various types of human cancers, such as bladder cancer7, prostatic small cell neuroendocrine carcinoma (SCNC)8, pancreatic cancer, gastric cancer9, glioblastoma10, and acute myeloid leukemia (AML)11. Here, PFKFB4 is linked to cancer.